Concepedia

Barbara Fingleton

BF

Statistics

Publications

65

Citations

9.7K

H-Index

45

Active since

1993

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

VA Tennessee Valley Healthcare System

Vanderbilt-Ingram Cancer Center

Stony Brook University

Barbara Fingleton is an author at Vanderbilt University specializing in oncology, medicine, and molecular oncology.

Publications per year

1993–2025

65

Publications

65

Matrix Metalloproteinases: Biologic Activity and Clinical Implications

Amy R. Nelson, Barbara Fingleton, Mace L. Rothenberg et al. · Journal of Clinical Oncology · 2000 · 1.6K citations

Medicine, Cancer Biology, Oncology +14

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Yang Li, Laura M. DeBusk, Koari Fukuda et al. · Cancer Cell · 2004 · 1.1K citations · Full text

Medicine, Immunology, Oncology +16

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1

Veerle Noë, Barbara Fingleton, Kathleen Jacobs et al. · Journal of Cell Science · 2001 · 688 citations

Life Sciences, Cell Biology, Molecular Biology +17

The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

Howard C. Crawford, Barbara Fingleton, Laura A. Rudolph‐Owen et al. · Oncogene · 1999 · 670 citations

Medicine, Cancer Biology, Oncology +15

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

William C. Powell, Barbara Fingleton, Carole L. Wilson et al. · Current Biology · 1999 · 422 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

1–5 of 65